If monitoring or auditing identifies serious and persistent noncompliance, what should the sponsor do?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

If monitoring or auditing identifies serious and persistent noncompliance, what should the sponsor do?

Explanation:
When monitoring or auditing reveals serious and persistent noncompliance, the sponsor must remove the investigator from participation and promptly inform regulatory authorities. This step protects study participants and preserves data integrity by stopping continued risk and ensuring oversight. Increasing monitoring or allowing continued participation does not adequately mitigate ongoing risk once noncompliance is both serious and persistent. Logging the issue or replacing staff without addressing the investigator also fails to resolve the core problem, which is that the investigator is not meeting essential GCP and protocol requirements.

When monitoring or auditing reveals serious and persistent noncompliance, the sponsor must remove the investigator from participation and promptly inform regulatory authorities. This step protects study participants and preserves data integrity by stopping continued risk and ensuring oversight. Increasing monitoring or allowing continued participation does not adequately mitigate ongoing risk once noncompliance is both serious and persistent. Logging the issue or replacing staff without addressing the investigator also fails to resolve the core problem, which is that the investigator is not meeting essential GCP and protocol requirements.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy